Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs United States Natural Gas Fund — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.28B), while United States Natural Gas Fund trades at $10.78 (market cap $522.93M). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 4.4× United States Natural Gas Fund's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| SLS | UNG | |
|---|---|---|
Market Cap | $2.28B | $522.93M |
Volume | 3,128,960 | 33,973,188 |
Sector | Health | Commodities - Energy |
52-Week High | $15.46 | $16.90 |
52-Week Low | $1.39 | $9.63 |
Enterprise Value | $2.15B | — |
Typical Hold Time | — | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UNG trades at $11.03, up 2.7% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported a net income of $65.15 million in 2024, though revenue was $0.00, and maintains a strong balance sheet with total assets of $790.02 million and minimal liabilities. Recent news highlights volatility in natural gas markets due to geopolitical tensions and record U.S. production.
The outlook for UNG is mixed, with bullish technicals and solid profitability offset by revenue uncertainty and market risks. Key opportunities include potential price support from geopolitical events, while risks involve natural gas price fluctuations and high production levels pressuring margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
